OmegaChem

OmegaChem Inc is a Canadian fine chemicals manufacturer founded in 1988, specializing in the development, manufacture, and distribution of high-value organic synthesis intermediates and niche specialty compounds for the pharmaceutical, biotechnology, and research sectors. The company's core product portfolio encompasses organofluorinated compounds,... chiral molecules derived from amino acids, and highly functionalized heterocyclic molecules, complemented by custom synthesis services, chemical process optimization, and research and development contracts that support customers from early-stage drug discovery through commercial-scale production. OmegaChem has built deep expertise across organic chemistry, medicinal chemistry, and process chemistry, enabling it to serve clients with complex molecular synthesis needs at scales ranging from milligram quantities to multi-kilogram batches. The company's technical capabilities are underpinned by a team of over 65 highly qualified scientists, the majority holding master's or doctoral degrees, supported by advanced laboratory facilities and high-tech equipment that facilitate rigorous development and scale-up work. In 2009, OmegaChem initiated two significant research projects focused on bioactive molecule identification within drug discovery programs, demonstrating its commitment to innovation beyond contract manufacturing. Recognizing opportunities for strategic expansion, the company founded BoroChem PBO in France in 2013 through an acquisition that brought specialized boron chemistry expertise into its portfolio, strengthening OmegaChem's competitive position in the pharmaceutical industry and broadening its service offerings to clients. The company's success is attributed to a combination of intellectual capital quality, collaborative teamwork, and a culture that rewards excellence and individual contribution, positioning OmegaChem as a trusted partner for organizations seeking reliable, sophisticated chemical synthesis and development support.Read More